SARS-CoV-2 infection can cause blood in the urine, and during the early waves of the pandemic this finding turned out to be surprisingly common among hospitalized patients. In one large Chinese cohort, roughly a quarter of hospitalized COVID-19 patients had detectable blood in their urine at the time of admission. The mechanisms behind it range from direct viral damage to the kidneys to immune overreactions that injure the kidney’s delicate filtering structures, and the presence of hematuria in a COVID patient carries real prognostic weight.
How Common Is It?
Among people sick enough to be hospitalized, blood in the urine has been a frequent laboratory finding. An analysis of 701 hospitalized patients in China found that about 27% had hematuria on admission, alongside proteinuria in roughly 44%.1Revista da Associação Médica Brasileira. Renal changes and acute kidney injury in covid-19: a systematic review That number reflects microscopic hematuria, blood cells visible under a microscope but not necessarily turning the urine visibly red. A separate study comparing urinalysis results before, during, and after COVID-19 confirmed that microscopic hematuria rose significantly during the active infection period and then dropped back down afterward.2Grand Journal of Urology. Comparison of Pre-COVID-19, COVID-19, and Post-COVID-19 Urinalysis Parameters and Assessment of Their Relationships with Renal Functions
Looking more broadly at all COVID patients, not just those hospitalized, the numbers are lower. A systematic review estimated the overall prevalence of lower urinary tract symptoms in COVID patients at about 3.3%, with hematuria listed among the most frequently reported complaints alongside urinary frequency and urgency.3Journal of Clinical Virology Plus. A systematic review on the correlation between COVID-19 and lower urinary tract symptoms So while mild or asymptomatic infections rarely cause noticeable urinary changes, moderate-to-severe illness appears to affect the urinary tract at a meaningful rate.
How the Virus Reaches the Kidneys
The kidneys are among the organs most vulnerable to SARS-CoV-2 because their cells carry high levels of ACE2, the surface protein the virus latches onto to enter cells. Research has demonstrated that kidney podocytes, specialized cells in the kidney’s filtering units, and proximal tubular cells, which line the small tubes where urine begins to form, can both be directly infected by the virus.4PubMed Central. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells Once the virus gets inside these cells, it can cause a cascade of damage: death of tubular cells, protein leaking through the kidney’s filters, collapse of filtering structures called glomeruli, and disruption of the cells’ energy-producing machinery.5PubMed Central. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms
That direct infection pathway helps explain why blood can show up in the urine even in patients whose COVID illness seems primarily respiratory. The kidneys filter all the blood in the body roughly every five minutes, so a circulating virus with an affinity for kidney cells has constant opportunity to reach and damage them. And the damage to tubular cells and glomeruli disrupts the barriers that normally keep red blood cells out of the urine.
Immune Reactions That Damage the Kidney’s Filters
Direct viral invasion is only one part of the picture. The immune system’s own response to SARS-CoV-2 can inflict collateral damage on the kidneys, sometimes severe enough to cause visible blood in the urine. One well-documented pattern involves IgA, an antibody the body produces heavily in response to mucosal infections like COVID-19. When this antibody is improperly assembled, it can form clumps that lodge in the kidney’s filtering units and trigger inflammation. This condition, IgA nephropathy, has become more frequently diagnosed since the pandemic began.6Scientific Reports. Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
A systematic review examining the mechanism found that SARS-CoV-2 drives up levels of IL-6, an inflammatory signaling molecule, which in turn causes abnormal modification of IgA1 antibodies. These malformed antibodies pair with other antibodies to form immune complexes that settle in tissues, especially the kidneys.7PubMed Central. The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review Patients who already had IgA nephropathy before catching COVID have experienced flare-ups, and some people have developed the condition for the first time during or after infection.8Frontiers in Medicine. Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review
Another immune-driven pattern goes by the name COVAN, short for COVID-19-associated nephropathy. This is a form of collapsing glomerulopathy, where the kidney’s filtering units essentially collapse and scar over. It was recognized early in the pandemic and has been documented in case series, sometimes with recovery after treatment.9PubMed Central. Successful treatment of COVID-19-associated collapsing glomerulopathy: 22 months of follow-up Both COVAN and IgA nephropathy can produce hematuria and proteinuria together, a combination that usually signals glomerular injury rather than a simple bladder or urinary tract issue.
Blood Clots in Tiny Kidney Vessels
COVID-19 is well known for promoting abnormal blood clotting, and the kidneys are not spared. A condition called thrombotic microangiopathy, where tiny clots form in the small blood vessels of the kidneys, has been documented in COVID patients. The proposed mechanism involves the virus damaging the inner lining of blood vessels, triggering an overactive inflammatory state, and activating the complement system, a part of innate immunity. This chain of events releases substances that promote clot formation in the kidney’s delicate microvasculature.10Frontiers in Medicine. Thrombotic microangiopathy with irreversible renal function in a CKD patient following COVID-19: case report
Beyond the kidneys specifically, SARS-CoV-2 damages endothelial barriers throughout the body, including the glomerular filtration barrier that keeps blood cells and proteins out of the urine. When these barriers break down, diffuse microthrombi form and multiple organs can be affected simultaneously. The kidney is especially vulnerable because its function depends entirely on intact vascular barriers separating blood from urine.
When the Problem Is Not the Kidneys
Not every case of blood in the urine during COVID points to kidney damage. Several other mechanisms can mimic or contribute to hematuria, and sorting them out matters because the treatments differ.
One striking mimic is rhabdomyolysis, the breakdown of muscle tissue that floods the bloodstream with myoglobin and other cellular contents. Myoglobin turns urine dark brown or red, closely resembling blood. In one reported case, a 50-year-old man presented with dark urine and decreased urine output as his first COVID symptoms, with creatine kinase levels far beyond normal, indicating massive muscle destruction.11PubMed Central. Dark urine as the initial manifestation of COVID-19: a case report The dark urine in rhabdomyolysis is not technically hematuria since the discoloration comes from myoglobin rather than intact red blood cells, but without lab testing the two are indistinguishable to the patient.
COVID-associated cystitis is another possibility. Some patients develop bladder inflammation during or after infection, presenting with symptoms that resemble overactive bladder: urgency, frequency, and sometimes blood.12PubMed Central. Prolonged impacts of COVID-19-associated cystitis: A study on long-term consequences Unlike kidney-origin hematuria, cystitis-related bleeding typically comes with painful urination and is more likely to produce visible blood rather than microscopic traces.
Medications used during COVID treatment can also contribute. Anticoagulants, which were widely prescribed to COVID patients because of the virus’s clotting tendency, can increase bleeding risk throughout the urinary tract. Even patients who developed hematuria following vaccination were noted to have heightened bleeding when they were already on blood thinners, though the bleeding resolved on its own.13PubMed Central. Gross Hematuria following SARS-CoV-2 Vaccination
Why Hematuria in COVID Patients Gets Taken Seriously
Blood in the urine is a common finding in many contexts, and in a healthy person it is often benign. In hospitalized COVID patients, though, the research consistently shows that hematuria on admission is a warning sign for worse outcomes. In one study, patients with hematuria at admission were significantly more likely to need ICU care, mechanical ventilation, and to die during their hospital stay. The association was strong: hematuria was linked to roughly an 18-fold increase in odds of death and a nearly 9-fold increase in odds of needing a ventilator after adjusting for other factors.14Kidney and Blood Pressure Research. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19
A separate study focusing specifically on red blood cells in the urine (erythrocyturia) at hospital admission found that it nearly tripled the odds of developing acute kidney injury during the hospital stay and more than doubled the odds of dying.15Nephrology Dialysis Transplantation. Erythrocyturia at Admission Is a Predictor of Acute Kidney Injury and In-Hospital Mortality in Hospitalized Patients with COVID-19 A retrospective cohort study found that dipstick hematuria predicted severe or critical illness with over a four-fold relative risk, and the combination of hematuria plus proteinuria was an even stronger predictor.16Clinical Kidney Journal. Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study
These findings prompted clinicians to use simple urine dipstick results as an early triage tool. One research group derived formulas using proteinuria and hematuria dipstick values to predict which patients would go on to develop acute kidney injury or need dialysis, incorporating baseline kidney function to improve accuracy.17PubMed Central. Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19 A cheap, widely available urine test, in other words, turned out to carry as much prognostic value as more expensive blood work in some settings.
Children and Multisystem Inflammatory Syndrome
Children with COVID-19 rarely develop severe kidney involvement, but there is a notable exception: multisystem inflammatory syndrome in children, or MIS-C. This delayed inflammatory reaction, which typically appears weeks after the initial infection, can produce hematuria alongside proteinuria. In one documented case, a boy with multiple comorbidities developed hematuria as an early sign of MIS-C. Further investigation found no underlying kidney disease, and the hematuria resolved after treatment with intravenous immunoglobulin, supporting the conclusion that it was part of the systemic inflammatory process rather than a sign of permanent kidney damage.18PubMed Central. Hematuria as an Early Sign of Multisystem Inflammatory Syndrome in Children: A Case Report of a Boy With Multiple Comorbidities and Review of Literature
The reassuring takeaway for parents is that hematuria in a child after COVID is rare and, in the MIS-C context, tends to resolve with appropriate treatment. But because MIS-C itself requires prompt medical attention, blood in a child’s urine weeks after a COVID infection warrants immediate evaluation.
Vaccination and Hematuria in People With IgA Nephropathy
Reports of visible blood in the urine after COVID mRNA vaccination drew attention early in the vaccination rollout, especially among people who already had IgA nephropathy. Research confirmed this was a real, though uncommon, phenomenon. A study of IgA nephropathy patients who experienced gross hematuria after vaccination found that they had a greater short-term decline in kidney function compared to those who did not. The group with post-vaccination hematuria showed a significantly steeper drop in their estimated kidney filtration rate in the months following vaccination, though by the study’s final follow-up the difference between the groups had evened out.19Scientific Reports. Gross hematuria after COVID-19 mRNA vaccination and kidney function trajectory in IgA nephropathy
Both infection and vaccination have been linked to IgA nephropathy flare-ups, with systematic reviews identifying cases of new-onset disease and worsening of pre-existing disease after vaccination.8Frontiers in Medicine. Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review The underlying mechanism appears similar in both scenarios: the immune stimulus, whether from the virus or the vaccine, drives the production of those poorly modified IgA antibodies that deposit in the kidneys.7PubMed Central. The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review For people with known IgA nephropathy, this is worth discussing with a nephrologist before vaccination, not as a reason to avoid it, but to set up appropriate monitoring.
Pandemic Disruptions and Missed Diagnoses
An indirect but practical consequence of the pandemic is that many people with blood in their urine from non-COVID causes delayed seeking medical care. Hematuria is a classic warning sign for kidney and bladder cancers, and pandemic-era disruptions affected how quickly those cancers were caught. Data from one study showed that monthly kidney cancer diagnoses dropped by about 10% during the pandemic period. The share of tumors found incidentally, on imaging done for other reasons, fell from about 82% to 72%, while the proportion of cancers discovered because of symptoms like hematuria ticked up.20PubMed Central. Changes in the Characteristics of Kidney Cancer Detection During the COVID-19 Pandemic When cancers are found because of symptoms rather than incidentally, they tend to be more advanced. Before the pandemic, symptomatic presentation was associated with roughly a 4.5-fold increase in the odds of advanced-stage disease.
The practical lesson here is that blood in the urine during or after COVID deserves medical attention even if a patient assumes it is virus-related. Hematuria has a long list of causes, from kidney stones and urinary tract infections to bladder and kidney cancer, and attributing it entirely to a recent COVID infection without investigation risks missing something else. A urine test, basic blood work, and sometimes imaging are straightforward steps that can either confirm a COVID-related cause or flag something that needs its own treatment.